Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

twoXAR

twoXAR
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$225K LATEST DEAL AMOUNT
7 INVESTORS
Description

Operator of an artificial intelligence-driven drug discovery company intended to build a pipeline of therapeutic candidates. The company leverages a computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships, providing clients with faster, cheaper and more accurate than traditional wet-lab based approaches.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Biotechnology
Primary Office
  • 883 North Shoreline Boulevard
  • Suite A100
  • Mountain View, CA 94043
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore twoXAR’s full profile, request a free trial.

twoXAR Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 28-Nov-2018 $225K 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 19-Mar-2018 0000 000.00 0000 Completed Generating Revenue
2. Seed Round 06-Nov-2015 $4.31M $4.31M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 24-Jun-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

twoXAR Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

twoXAR Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Genomics Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000 Private Equity-Backed Princeton, NJ 000 0000 000000000 0000
000000000000 Private Equity-Backed London, United Kingdom 000 00000 0000000 0000 00000
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 00000000000 0000
0000000 00000000 Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
To view this company’s complete list of competitors, request access »

twoXAR Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
OS Fund Venture Capital Minority 000 0000 000000 0
SoftBank Ventures Asia Corporate Venture Capital Minority 000 0000 000000 0
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
Stex25 Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

twoXAR Executive Team (6)

Name Title Board
Seat
Contact
Info
Andrew Radin Co-Founder, Chief Executive Officer & Board Member
Brian Moriarty Chief Financial Officer & Board Member
Andrew Radin Co-Founder & Advisor
Jonathan MacQuitty Ph.D Advisor
Vijay Pande Ph.D Scientific Advisor

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

twoXAR Board Members (4)

Name Representing Role Since Contact
Info
Andrew Radin twoXAR Co-Founder, Chief Executive Officer & Board Member 000 0000
Brian Moriarty twoXAR Chief Financial Officer & Board Member 000 0000
Joonpyo Lee SoftBank Ventures Asia Board Member 000 0000
Jorge Conde Andreessen Horowitz Board Member 000 0000